APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 2 Diabetes Mellitus Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Type 2 Diabetes Mellitus Treatment Market Outlook and Growth Opportunities 2026

Report ID 174043970427 December 2025195 pages

Choose your research edition.

Industry ResearchType 2 Diabetes Mellitus Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 2 Diabetes Mellitus Treatment Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Type 2 Diabetes Mellitus Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 2 Diabetes Mellitus Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 2 Diabetes Mellitus Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Type 2 Diabetes Mellitus Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Type 2 Diabetes Mellitus Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Type 2 Diabetes Mellitus Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Type 2 Diabetes Mellitus Treatment market include Takeda Pharmaceutical Co. Ltd, Sanofi SA, Novartis AG, Novo Nordisk AS, Merck & Co. Inc, Eli Lilly and Co., Daiichi Sankyo Co. Ltd, Boehringer Ingelheim International GmbH and AstraZeneca PLC, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Type 2 Diabetes Mellitus Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Type 2 Diabetes Mellitus Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Type 2 Diabetes Mellitus Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Type 2 Diabetes Mellitus Treatment market.

Type 2 Diabetes Mellitus Treatment Segment by Company

Takeda Pharmaceutical Co. Ltd

Sanofi SA

Novartis AG

Novo Nordisk AS

Merck & Co. Inc

Eli Lilly and Co.

Daiichi Sankyo Co. Ltd

Boehringer Ingelheim International GmbH

AstraZeneca PLC

Type 2 Diabetes Mellitus Treatment Segment by Type

Insulin

SGLT2 Inhibitors

GLP-1 Receptor Agonists

DPP-4 Inhibitors

Others

Type 2 Diabetes Mellitus Treatment Segment by Application

Hospitals

Clinics

Other

Type 2 Diabetes Mellitus Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Type 2 Diabetes Mellitus Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Type 2 Diabetes Mellitus Treatment key companies, revenue, market share, and recent developments.

3. To split the Type 2 Diabetes Mellitus Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Type 2 Diabetes Mellitus Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Type 2 Diabetes Mellitus Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Type 2 Diabetes Mellitus Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 2 Diabetes Mellitus Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 2 Diabetes Mellitus Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 2 Diabetes Mellitus Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Type 2 Diabetes Mellitus Treatment industry.

Chapter 3: Detailed analysis of Type 2 Diabetes Mellitus Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Type 2 Diabetes Mellitus Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Type 2 Diabetes Mellitus Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Type 2 Diabetes Mellitus Treatment Industry Trends Table 2. Type 2 Diabetes Mellitus Treatment Industry Drivers Table 3. Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges Table 4. Type 2 Diabetes Mellitus Treatment Industry Restraints Table 5. Global Type 2 Diabetes Mellitus Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Type 2 Diabetes Mellitus Treatment Revenue Share by Company (2021-2026) Table 7. Global Type 2 Diabetes Mellitus Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Type 2 Diabetes Mellitus Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Type 2 Diabetes Mellitus Treatment Company, Product Type & Application Table 10. Global Type 2 Diabetes Mellitus Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Type 2 Diabetes Mellitus Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Insulin Table 15. Significant Companies of SGLT2 Inhibitors Table 16. Significant Companies of GLP-1 Receptor Agonists Table 17. Significant Companies of DPP-4 Inhibitors Table 18. Significant Companies of Others Table 19. Global Type 2 Diabetes Mellitus Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Type 2 Diabetes Mellitus Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Type 2 Diabetes Mellitus Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Type (2021-2026) Table 23. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Clinics Table 26. Significant Companies of Other Table 27. Global Type 2 Diabetes Mellitus Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Type 2 Diabetes Mellitus Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Type 2 Diabetes Mellitus Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Application (2021-2026) Table 31. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Application (2027-2032) Table 32. Global Type 2 Diabetes Mellitus Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Type 2 Diabetes Mellitus Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Region (2021-2026) Table 35. Global Type 2 Diabetes Mellitus Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Region (2027-2032) Table 37. Global Type 2 Diabetes Mellitus Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Type 2 Diabetes Mellitus Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Type 2 Diabetes Mellitus Treatment Sales Value Market Share by Country (2021-2026) Table 40. Global Type 2 Diabetes Mellitus Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Type 2 Diabetes Mellitus Treatment Sales Value Market Share by Country (2027-2032) Table 42. Takeda Pharmaceutical Co. Ltd Company Information Table 43. Takeda Pharmaceutical Co. Ltd Business Overview Table 44. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 46. Takeda Pharmaceutical Co. Ltd Recent Development Table 47. Sanofi SA Company Information Table 48. Sanofi SA Business Overview Table 49. Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio Table 51. Sanofi SA Recent Development Table 52. Novartis AG Company Information Table 53. Novartis AG Business Overview Table 54. Novartis AG Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio Table 56. Novartis AG Recent Development Table 57. Novo Nordisk AS Company Information Table 58. Novo Nordisk AS Business Overview Table 59. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio Table 61. Novo Nordisk AS Recent Development Table 62. Merck & Co. Inc Company Information Table 63. Merck & Co. Inc Business Overview Table 64. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio Table 66. Merck & Co. Inc Recent Development Table 67. Eli Lilly and Co. Company Information Table 68. Eli Lilly and Co. Business Overview Table 69. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio Table 71. Eli Lilly and Co. Recent Development Table 72. Daiichi Sankyo Co. Ltd Company Information Table 73. Daiichi Sankyo Co. Ltd Business Overview Table 74. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio Table 76. Daiichi Sankyo Co. Ltd Recent Development Table 77. Boehringer Ingelheim International GmbH Company Information Table 78. Boehringer Ingelheim International GmbH Business Overview Table 79. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio Table 81. Boehringer Ingelheim International GmbH Recent Development Table 82. AstraZeneca PLC Company Information Table 83. AstraZeneca PLC Business Overview Table 84. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio Table 86. AstraZeneca PLC Recent Development Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Type 2 Diabetes Mellitus Treatment Product Image Figure 2. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 2 Diabetes Mellitus Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Type 2 Diabetes Mellitus Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Insulin Image Figure 8. SGLT2 Inhibitors Image Figure 9. GLP-1 Receptor Agonists Image Figure 10. DPP-4 Inhibitors Image Figure 11. Others Image Figure 12. Global Type 2 Diabetes Mellitus Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Type 2 Diabetes Mellitus Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Clinics Image Figure 17. Other Image Figure 18. Global Type 2 Diabetes Mellitus Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Type 2 Diabetes Mellitus Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Application (2021-2032) Figure 21. Global Type 2 Diabetes Mellitus Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. North America Type 2 Diabetes Mellitus Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Type 2 Diabetes Mellitus Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Type 2 Diabetes Mellitus Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. South America Type 2 Diabetes Mellitus Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Type 2 Diabetes Mellitus Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • SGLT2 Inhibitors
  • GLP-1 Receptor Agonists
  • DPP-4 Inhibitors
  • Others
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Co. Ltd
  • Sanofi SA
  • Novartis AG
  • Novo Nordisk AS
  • Merck & Co. Inc
  • Eli Lilly and Co.
  • Daiichi Sankyo Co. Ltd
  • Boehringer Ingelheim International GmbH
  • AstraZeneca PLC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Type 2 Diabetes Mellitus Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Type 2 Diabetes Mellitus Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Type 2 Diabetes Mellitus Treatment Market Dynamics
  1. 2.1 Type 2 Diabetes Mellitus Treatment Industry Trends
  2. 2.2 Type 2 Diabetes Mellitus Treatment Industry Drivers
  3. 2.3 Type 2 Diabetes Mellitus Treatment Industry Opportunities and Challenges
  4. 2.4 Type 2 Diabetes Mellitus Treatment Industry Restraints
3 Type 2 Diabetes Mellitus Treatment Market by Company
  1. 3.1 Global Type 2 Diabetes Mellitus Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Type 2 Diabetes Mellitus Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Type 2 Diabetes Mellitus Treatment Company Ranking (2024-2026)
  4. 3.4 Global Type 2 Diabetes Mellitus Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Type 2 Diabetes Mellitus Treatment Company Product Type and Application
  6. 3.6 Global Type 2 Diabetes Mellitus Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Type 2 Diabetes Mellitus Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Type 2 Diabetes Mellitus Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Type 2 Diabetes Mellitus Treatment Market by Type
  1. 4.1 Type 2 Diabetes Mellitus Treatment Type Introduction
  2. 4.1.1 Insulin
  3. 4.1.2 SGLT2 Inhibitors
  4. 4.1.3 GLP-1 Receptor Agonists
  5. 4.1.4 DPP-4 Inhibitors
  6. 4.1.5 Others
  7. 4.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Type
  8. 4.2.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Type (2021-2032)
  10. 4.2.3 Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Type (2021-2032)
5 Type 2 Diabetes Mellitus Treatment Market by Application
  1. 5.1 Type 2 Diabetes Mellitus Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Application
  6. 5.2.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Type 2 Diabetes Mellitus Treatment Sales Value Share by Application (2021-2032)
6 Type 2 Diabetes Mellitus Treatment Regional Value Analysis
  1. 6.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Type 2 Diabetes Mellitus Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Type 2 Diabetes Mellitus Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Type 2 Diabetes Mellitus Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Type 2 Diabetes Mellitus Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Type 2 Diabetes Mellitus Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Type 2 Diabetes Mellitus Treatment Sales Value Share by Country, 2025 VS 2032
7 Type 2 Diabetes Mellitus Treatment Country-level Value Analysis
  1. 7.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Type 2 Diabetes Mellitus Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Type 2 Diabetes Mellitus Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Type 2 Diabetes Mellitus Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Type 2 Diabetes Mellitus Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Type 2 Diabetes Mellitus Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Co. Ltd
  2. 8.1.1 Takeda Pharmaceutical Co. Ltd Company Information
  3. 8.1.2 Takeda Pharmaceutical Co. Ltd Business Overview
  4. 8.1.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Co. Ltd Recent Developments
  7. 8.2 Sanofi SA
  8. 8.2.1 Sanofi SA Company Information
  9. 8.2.2 Sanofi SA Business Overview
  10. 8.2.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi SA Type 2 Diabetes Mellitus Treatment Product Portfolio
  12. 8.2.5 Sanofi SA Recent Developments
  13. 8.3 Novartis AG
  14. 8.3.1 Novartis AG Company Information
  15. 8.3.2 Novartis AG Business Overview
  16. 8.3.3 Novartis AG Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis AG Type 2 Diabetes Mellitus Treatment Product Portfolio
  18. 8.3.5 Novartis AG Recent Developments
  19. 8.4 Novo Nordisk AS
  20. 8.4.1 Novo Nordisk AS Company Information
  21. 8.4.2 Novo Nordisk AS Business Overview
  22. 8.4.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product Portfolio
  24. 8.4.5 Novo Nordisk AS Recent Developments
  25. 8.5 Merck & Co. Inc
  26. 8.5.1 Merck & Co. Inc Company Information
  27. 8.5.2 Merck & Co. Inc Business Overview
  28. 8.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product Portfolio
  30. 8.5.5 Merck & Co. Inc Recent Developments
  31. 8.6 Eli Lilly and Co.
  32. 8.6.1 Eli Lilly and Co. Company Information
  33. 8.6.2 Eli Lilly and Co. Business Overview
  34. 8.6.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product Portfolio
  36. 8.6.5 Eli Lilly and Co. Recent Developments
  37. 8.7 Daiichi Sankyo Co. Ltd
  38. 8.7.1 Daiichi Sankyo Co. Ltd Company Information
  39. 8.7.2 Daiichi Sankyo Co. Ltd Business Overview
  40. 8.7.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product Portfolio
  42. 8.7.5 Daiichi Sankyo Co. Ltd Recent Developments
  43. 8.8 Boehringer Ingelheim International GmbH
  44. 8.8.1 Boehringer Ingelheim International GmbH Company Information
  45. 8.8.2 Boehringer Ingelheim International GmbH Business Overview
  46. 8.8.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product Portfolio
  48. 8.8.5 Boehringer Ingelheim International GmbH Recent Developments
  49. 8.9 AstraZeneca PLC
  50. 8.9.1 AstraZeneca PLC Company Information
  51. 8.9.2 AstraZeneca PLC Business Overview
  52. 8.9.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product Portfolio
  54. 8.9.5 AstraZeneca PLC Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst